{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:11:57Z","timestamp":1790014317345,"version":"4.0.1"},"reference-count":282,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["323B2050"],"award-info":[{"award-number":["323B2050"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M782195"],"award-info":[{"award-number":["2025M782195"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["ZYGD23038"],"award-info":[{"award-number":["ZYGD23038"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC2310700"],"award-info":[{"award-number":["2024YFC2310700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2023NSFSC1655"],"award-info":[{"award-number":["2023NSFSC1655"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes & Diseases"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.gendis.2026.102200","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T16:15:37Z","timestamp":1776788137000},"page":"102200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Respiratory mucosal immunity: Biological functions, diseases, prevention and therapy"],"prefix":"10.1016","volume":"13","author":[{"given":"Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7179-4069","authenticated-orcid":false,"given":"Zhiruo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiawei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib1","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2368288","article-title":"Induction of protective immune responses at respiratory mucosal sites","volume":"20","author":"Park","year":"2024","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anl.2021.07.003","article-title":"The mucosal immune system of the upper respiratory tract and recent progress in mucosal vaccines","volume":"49","author":"Kurono","year":"2022","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.gendis.2026.102200_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1358885","article-title":"Mucosal immunity in upper and lower respiratory tract to MERS-CoV","volume":"15","author":"Shrwani","year":"2024","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.gendis.2026.102200_bib4","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.immuni.2022.04.013","article-title":"Mucosal immune responses to infection and vaccination in the respiratory tract","volume":"55","author":"Mettelman","year":"2022","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.gendis.2026.102200_bib5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.mucimm.2025.04.001","article-title":"Innate immunity of the lungs in homeostasis and disease","volume":"18","author":"Norris","year":"2025","journal-title":"Mucosal Immunol"},{"issue":"5","key":"10.1016\/j.gendis.2026.102200_bib6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3390\/v14050933","article-title":"Innate and adaptive immune responses in the upper respiratory tract and the infectivity of SARS-CoV-2","volume":"14","author":"Ramasamy","year":"2022","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.gendis.2026.102200_bib7","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cmi.2021.05.034","article-title":"The association between bacteria colonizing the upper respiratory tract and lower respiratory tract infection in young children: a systematic review and meta-analysis","volume":"27","author":"Claassen-Weitz","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1016\/j.gendis.2026.102200_bib8","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ni1101-1004","article-title":"Collaboration of epithelial cells with organized mucosal lymphoid tissues","volume":"2","author":"Neutra","year":"2001","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.gendis.2026.102200_bib9","first-page":"336","article-title":"Upper airway defence mechanisms","volume":"1","author":"Fokkens","year":"2000","journal-title":"Paediatr Respir Rev"},{"issue":"8","key":"10.1016\/j.gendis.2026.102200_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.658","article-title":"Macrophage plasticity: signaling pathways, tissue repair, and regeneration","volume":"5","author":"Yan","year":"2024","journal-title":"MedComm"},{"issue":"4","key":"10.1016\/j.gendis.2026.102200_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41577-019-0244-2","article-title":"B cell memory: building two walls of protection against pathogens","volume":"20","author":"Akkaya","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.gendis.2026.102200_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1216402","article-title":"Pivotal role of tissue-resident memory lymphocytes in the control of mucosal infections: can mucosal vaccination induce protective tissue-resident memory T and B cells?","volume":"14","author":"Longet","year":"2023","journal-title":"Front Immunol"},{"issue":"163","key":"10.1016\/j.gendis.2026.102200_bib13","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0112-2021","article-title":"Role of air pollutants in airway epithelial barrier dysfunction in asthma and COPD","volume":"31","author":"Aghapour","year":"2022","journal-title":"Eur Respir Rev"},{"issue":"11","key":"10.1016\/j.gendis.2026.102200_bib14","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.3390\/ijms25116178","article-title":"Immune response to respiratory viral infections","volume":"25","author":"Gambadauro","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.gendis.2026.102200_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.molmed.2023.01.003","article-title":"Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines","volume":"29","author":"Fraser","year":"2023","journal-title":"Trends Mol Med"},{"issue":"76","key":"10.1016\/j.gendis.2026.102200_bib16","doi-asserted-by":"crossref","first-page":"eadd4853","DOI":"10.1126\/sciimmunol.add4853","article-title":"Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination","volume":"7","author":"Tang","year":"2022","journal-title":"Sci Immunol"},{"issue":"2","key":"10.1016\/j.gendis.2026.102200_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/v14020187","article-title":"Mucosal vaccines, sterilizing immunity, and the future of SARS-CoV-2 virulence","volume":"14","author":"Focosi","year":"2022","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.gendis.2026.102200_bib18","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.cell.2022.02.005","article-title":"Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2","volume":"185","author":"Afkhami","year":"2022","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.gendis.2026.102200_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.tips.2022.11.006","article-title":"Inhalable neutralizing antibodies\u2013promising approach to combating respiratory viral infections","volume":"44","author":"Chow","year":"2023","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"10.1016\/j.gendis.2026.102200_bib20","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/s41590-024-01951-5","article-title":"Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman Primates","volume":"25","author":"Gagne","year":"2024","journal-title":"Nat Immunol"},{"issue":"20","key":"10.1016\/j.gendis.2026.102200_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.182836","article-title":"Limited nasal IFN production contributes to delayed respiratory virus clearance and suboptimal vaccine responses","volume":"10","author":"Sojati","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.gendis.2026.102200_bib22","doi-asserted-by":"crossref","first-page":"101397","DOI":"10.1016\/j.coviro.2024.101397","article-title":"Tissue-resident memory T cells in protective immunity to influenza virus","volume":"65","author":"Lee","year":"2024","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.gendis.2026.102200_bib23","doi-asserted-by":"crossref","first-page":"110026","DOI":"10.1016\/j.virol.2024.110026","article-title":"Mucosal vaccines for viral diseases: status and prospects","volume":"593","author":"Ma","year":"2024","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.gendis.2026.102200_bib24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","article-title":"Mucosal vaccines: fortifying the frontiers","volume":"22","author":"Lavelle","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.gendis.2026.102200_bib25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/vaccines12020191","article-title":"Vaccine strategies to elicit mucosal immunity","volume":"12","author":"Song","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"12","key":"10.1016\/j.gendis.2026.102200_bib26","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1016\/j.apsb.2024.08.026","article-title":"Respiratory delivered vaccines: current status and perspectives in rational formulation design","volume":"14","author":"Wu","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.gendis.2026.102200_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1419527","article-title":"Harnessing the potential of the NALT and BALT as targets for immunomodulation using engineering strategies to enhance mucosal uptake","volume":"15","author":"Seefeld","year":"2024","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.gendis.2026.102200_bib28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.coviro.2012.03.009","article-title":"The mucosal immune system of the respiratory tract","volume":"2","author":"Sato","year":"2012","journal-title":"Curr Opin Virol"},{"issue":"8","key":"10.1016\/j.gendis.2026.102200_bib29","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/s41590-023-01573-3","article-title":"Formation of bronchus-associated lymphoid tissue (BALT) for early life immune protection","volume":"24","year":"2023","journal-title":"Nat Immunol"},{"issue":"8","key":"10.1016\/j.gendis.2026.102200_bib30","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/s41590-023-01566-2","article-title":"The case for BALT in human respiratory immunity","volume":"24","author":"Ding","year":"2023","journal-title":"Nat Immunol"},{"key":"10.1016\/j.gendis.2026.102200_bib31","doi-asserted-by":"crossref","first-page":"118326","DOI":"10.1016\/j.biopha.2025.118326","article-title":"Respiratory mucosal vaccines: applications, delivery strategies and design considerations","volume":"189","author":"Shi","year":"2025","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.gendis.2026.102200_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3390\/pathogens13020113","article-title":"Mucosal immunity against SARS-CoV-2 in the respiratory tract","volume":"13","author":"Noh","year":"2024","journal-title":"Pathogens"},{"issue":"8025","key":"10.1016\/j.gendis.2026.102200_bib33","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41586-024-07729-x","article-title":"Turbinate-homing IgA-secreting cells originate in the nasal lymphoid tissues","volume":"632","author":"Liu","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib34","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41392-024-01822-3","article-title":"Nasal vaccination of triple-RBD scaffold protein with flagellin elicits long-term protection against SARS-CoV-2 variants including JN.1","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.gendis.2026.102200_bib35","doi-asserted-by":"crossref","first-page":"101847","DOI":"10.1016\/j.smim.2023.101847","article-title":"Regulatory T cells in allergic inflammation","volume":"70","author":"Benamar","year":"2023","journal-title":"Semin Immunol"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib36","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41392-025-02326-4","article-title":"Regulatory T cells in homeostasis and disease: molecular mechanisms and therapeutic potential","volume":"10","author":"Wang","year":"2025","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"10.1016\/j.gendis.2026.102200_bib37","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.gendis.2026.102200_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1444533","article-title":"Epigenetic regulation of human FOXP3+ Tregs: from homeostasis maintenance to pathogen defense","volume":"15","author":"Yue","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.it.2020.11.001","article-title":"Tolerogenic dendritic cells in autoimmunity and inflammatory diseases","volume":"42","author":"Morante-Palacios","year":"2021","journal-title":"Trends Immunol"},{"issue":"8","key":"10.1016\/j.gendis.2026.102200_bib40","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","article-title":"Short-chain fatty acids: linking diet, the microbiome and immunity","volume":"24","author":"Mann","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.gendis.2026.102200_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1004339","article-title":"Regulation of T cell repertoires by commensal microbiota","volume":"12","author":"Kim","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"10.1016\/j.gendis.2026.102200_bib42","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.gendis.2026.102200_bib43","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1439","article-title":"NALT- versus Peyer\u2019s-patch-mediated mucosal immunity","volume":"4","author":"Kiyono","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41385-019-0206-9","article-title":"Targeting the IL-22\/IL-22BP axis enhances tight junctions and reduces inflammation during influenza infection","volume":"13","author":"Hebert","year":"2020","journal-title":"Mucosal Immunol"},{"issue":"2","key":"10.1016\/j.gendis.2026.102200_bib45","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/mi.2012.81","article-title":"Molecular organization of the mucins and glycocalyx underlying mucus transport over mucosal surfaces of the airways","volume":"6","author":"Kesimer","year":"2013","journal-title":"Mucosal Immunol"},{"issue":"4","key":"10.1016\/j.gendis.2026.102200_bib46","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1248\/bpb.b14-00398","article-title":"The effect of Cilia and the mucociliary clearance on successful drug delivery","volume":"38","author":"Gizurarson","year":"2015","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"10.1016\/j.gendis.2026.102200_bib47","doi-asserted-by":"crossref","DOI":"10.4161\/tisb.24997","article-title":"Barrier function of airway tract epithelium","volume":"1","author":"Ganesan","year":"2013","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.gendis.2026.102200_bib48","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3389\/fimmu.2020.01198","article-title":"Expression and roles of antimicrobial peptides in innate defense of airway mucosa: potential implication in cystic fibrosis","volume":"11","author":"Geitani","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.gendis.2026.102200_bib49","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/jam.15314","article-title":"Antimicrobial peptides (AMPs): a promising class of antimicrobial compounds","volume":"132","author":"Erdem B\u00fcy\u00fckkiraz","year":"2022","journal-title":"J Appl Microbiol"},{"issue":"9","key":"10.1016\/j.gendis.2026.102200_bib50","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3390\/antibiotics13090794","article-title":"Antimicrobial peptides and their biomedical applications: a review","volume":"13","author":"Min","year":"2024","journal-title":"Antibiotics (Basel)"},{"issue":"4","key":"10.1016\/j.gendis.2026.102200_bib51","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/s41385-021-00397-4","article-title":"Neutrophils in respiratory viral infections","volume":"14","author":"Johansson","year":"2021","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.gendis.2026.102200_bib52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","article-title":"Diversity, mechanisms, and significance of macrophage plasticity","volume":"15","author":"Locati","year":"2020","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"10.1016\/j.gendis.2026.102200_bib53","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02248-2020","article-title":"Macrophage-derived IL-6 trans-signalling as a novel target in the pathogenesis of bronchopulmonary dysplasia","volume":"59","author":"Hirani","year":"2022","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.gendis.2026.102200_bib54","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/dna.2024.0211","article-title":"Guardians of the lung: the multifaceted roles of macrophages in cancer and infectious disease","volume":"44","author":"Liu","year":"2025","journal-title":"DNA Cell Biol"},{"issue":"2","key":"10.1016\/j.gendis.2026.102200_bib55","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.imbio.2018.11.010","article-title":"Reactive oxygen species (ROS) in macrophage activation and function in diabetes","volume":"224","author":"Rendra","year":"2019","journal-title":"Immunobiology"},{"issue":"5","key":"10.1016\/j.gendis.2026.102200_bib56","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/jre.12912","article-title":"Hyperglycemia modulates M1\/M2 macrophage polarization via reactive oxygen species overproduction in ligature-induced periodontitis","volume":"56","author":"Zhang","year":"2021","journal-title":"J Periodontal Res"},{"key":"10.1016\/j.gendis.2026.102200_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1173899","article-title":"Sialidase facilitates Porphyromonas gingivalis immune evasion by reducing M1 polarization, antigen presentation, and phagocytosis of infected macrophages","volume":"13","author":"Fan","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.gendis.2026.102200_bib58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3389\/fcimb.2017.00373","article-title":"Neutrophils to the ROScue: mechanisms of NADPH oxidase activation and bacterial resistance","volume":"7","author":"Nguyen","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"10.1016\/j.gendis.2026.102200_bib59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/omi.12252","article-title":"The roles of NADPH oxidase in modulating neutrophil effector responses","volume":"34","author":"Zeng","year":"2019","journal-title":"Mol Oral Microbiol"},{"issue":"6","key":"10.1016\/j.gendis.2026.102200_bib60","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1089\/ars.2013.5447","article-title":"Are reactive oxygen species always detrimental to pathogens?","volume":"20","author":"Paiva","year":"2014","journal-title":"Antioxid Redox Signaling"},{"issue":"7","key":"10.1016\/j.gendis.2026.102200_bib61","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.immuni.2021.06.006","article-title":"The neutrophil","volume":"54","author":"Burn","year":"2021","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.gendis.2026.102200_bib62","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.4049\/jimmunol.178.4.2448","article-title":"Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice","volume":"178","author":"Hashimoto","year":"2007","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.gendis.2026.102200_bib63","first-page":"1178","article-title":"NETosis: molecular mechanisms, role in physiology and pathology","volume":"85","author":"Vorobjeva","year":"2020","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.gendis.2026.102200_bib64","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.immuni.2023.06.018","article-title":"Innate immunity and interferon in SARS-CoV-2 infection outcome","volume":"56","author":"Savan","year":"2023","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.gendis.2026.102200_bib65","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s12276-023-01022-z","article-title":"Versatile roles of innate lymphoid cells at the mucosal barrier: from homeostasis to pathological inflammation","volume":"55","author":"Ryu","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.gendis.2026.102200_bib66","doi-asserted-by":"crossref","first-page":"104811","DOI":"10.1016\/j.antiviral.2020.104811","article-title":"Antiviral activities of type I interferons to SARS-CoV-2 infection","volume":"179","author":"Mantlo","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.gendis.2026.102200_bib67","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.83055","article-title":"Transiently heritable fates and quorum sensing drive early IFN-I response dynamics","volume":"12","author":"Van Eyndhoven","year":"2023","journal-title":"Elife"},{"issue":"7","key":"10.1016\/j.gendis.2026.102200_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350955","article-title":"Immune quorum sensing dictates IFN-I response dynamics in human plasmacytoid dendritic cells","volume":"54","author":"Van Eyndhoven","year":"2024","journal-title":"Eur J Immunol"},{"issue":"6","key":"10.1016\/j.gendis.2026.102200_bib69","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s004289900177","article-title":"Evidence of M cells as portals of entry for antigens in the nasopharyngeal lymphoid tissue of humans","volume":"436","author":"Fujimura","year":"2000","journal-title":"Virchows Arch"},{"issue":"2","key":"10.1016\/j.gendis.2026.102200_bib70","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.immuni.2006.01.005","article-title":"Dendritic cells rapidly recruited into epithelial tissues via CCR6\/CCL20 are responsible for CD8+ T cell crosspriming in vivo","volume":"24","author":"Le Borgne","year":"2006","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00281-024-01027-4","article-title":"Role of mucosal IgA antibodies as novel therapies to enhance mucosal barriers","volume":"47","author":"Gao","year":"2024","journal-title":"Semin Immunopathol"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib72","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4049\/jimmunol.182.1.5","article-title":"The surprising discovery that TGF beta specifically induces the IgA class switch","volume":"182","author":"Stavnezer","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.gendis.2026.102200_bib73","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jconrel.2023.02.011","article-title":"Recent advances in respiratory immunization: a focus on COVID-19 vaccines","volume":"355","author":"He","year":"2023","journal-title":"J Control Release"},{"issue":"4","key":"10.1016\/j.gendis.2026.102200_bib74","doi-asserted-by":"crossref","first-page":"C1161","DOI":"10.1152\/ajpcell.00338.2022","article-title":"The multifunctional nature of CD103 (\u03b1E\u03b27 integrin) signaling in tissue-resident lymphocytes","volume":"323","author":"Xu","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"10.1016\/j.gendis.2026.102200_bib75","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41385-021-00461-z","article-title":"Tissue resident memory T cells in the respiratory tract","volume":"15","author":"Zheng","year":"2022","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.gendis.2026.102200_bib76","doi-asserted-by":"crossref","first-page":"102278","DOI":"10.1016\/j.coi.2022.102278","article-title":"Lung tissue-resident memory T cells: the gatekeeper to respiratory viral (re)-infection","volume":"80","author":"Tang","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.gendis.2026.102200_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1433452","article-title":"Mucosal immunity in COVID-19: a comprehensive review","volume":"15","author":"Alqahtani","year":"2024","journal-title":"Front Immunol"},{"issue":"8062","key":"10.1016\/j.gendis.2026.102200_bib78","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-025-08910-6","article-title":"Nasal vaccines for respiratory infections","volume":"641","author":"Kiyono","year":"2025","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.gendis.2026.102200_bib79","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1046\/j.1365-3083.2000.00790.x","article-title":"Role of J chain in secretory immunoglobulin formation","volume":"52","author":"Johansen","year":"2000","journal-title":"Scand J Immunol"},{"issue":"3","key":"10.1016\/j.gendis.2026.102200_bib80","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.4049\/jimmunol.178.3.1589","article-title":"Secretory antibody formation: conserved binding interactions between J chain and polymeric ig receptor from humans and amphibians","volume":"178","author":"Braathen","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.gendis.2026.102200_bib81","doi-asserted-by":"crossref","first-page":"105823","DOI":"10.1016\/j.antiviral.2024.105823","article-title":"Unmasking the potential of secretory IgA and its pivotal role in protection from respiratory viruses","volume":"223","author":"Sinha","year":"2024","journal-title":"Antivir Res"},{"issue":"3","key":"10.1016\/j.gendis.2026.102200_bib82","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/imcb.12235","article-title":"Airway macrophages as the guardians of tissue repair in the lung","volume":"97","author":"Puttur","year":"2019","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.gendis.2026.102200_bib83","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3389\/fimmu.2020.01315","article-title":"IL-10 and IL-22 in mucosal immunity: driving protection and pathology","volume":"11","author":"Wei","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.gendis.2026.102200_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.586471","article-title":"The role of group 3 innate lymphoid cells in lung infection and immunity","volume":"11","author":"Yang","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"10.1016\/j.gendis.2026.102200_bib85","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cell.2019.03.016","article-title":"B cell responses: cell interaction dynamics and decisions","volume":"177","author":"Cyster","year":"2019","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.gendis.2026.102200_bib86","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1111\/febs.16385","article-title":"Dynamic organization of the bone marrow plasma cell niche","volume":"289","author":"Aaron","year":"2022","journal-title":"FEBS J"},{"issue":"11","key":"10.1016\/j.gendis.2026.102200_bib87","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1128\/JVI.75.11.5416-5420.2001","article-title":"Nasal-associated lymphoid tissue is a site of long-term virus-specific antibody production following respiratory virus infection of mice","volume":"75","author":"Liang","year":"2001","journal-title":"J Virol"},{"issue":"21","key":"10.1016\/j.gendis.2026.102200_bib88","doi-asserted-by":"crossref","first-page":"11303","DOI":"10.1128\/JVI.77.21.11303-11311.2003","article-title":"Inability to evoke a long-lasting protective immune response to respiratory syncytial virus infection in mice correlates with ineffective nasal antibody responses","volume":"77","author":"Singleton","year":"2003","journal-title":"J Virol"},{"issue":"7604","key":"10.1016\/j.gendis.2026.102200_bib89","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature17979","article-title":"Access of protective antiviral antibody to neuronal tissues requires CD4 T-cell help","volume":"533","author":"Iijima","year":"2016","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.gendis.2026.102200_bib90","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.immuni.2022.08.017","article-title":"Mucosal plasma cells are required to protect the upper airway and brain from infection","volume":"55","author":"Wellford","year":"2022","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.gendis.2026.102200_bib91","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.immuni.2022.10.012","article-title":"Upper airway and brain protection by plasma cells: a local affair","volume":"55","author":"Cornelis","year":"2022","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib92","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41590-018-0260-6","article-title":"The establishment of resident memory B cells in the lung requires local antigen encounter","volume":"20","author":"Allie","year":"2019","journal-title":"Nat Immunol"},{"issue":"66","key":"10.1016\/j.gendis.2026.102200_bib93","doi-asserted-by":"crossref","first-page":"eabj5129","DOI":"10.1126\/sciimmunol.abj5129","article-title":"Intranasal priming induces local lung-resident B cell populations that secrete protective mucosal antiviral IgA","volume":"6","author":"Oh","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.gendis.2026.102200_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.738955","article-title":"Pulmonary-resident memory lymphocytes: pivotal orchestrators of local immunity against respiratory infections","volume":"12","author":"Humphries","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.gendis.2026.102200_bib95","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/mi.2007.14","article-title":"Differentiation and homing of IgA-secreting cells","volume":"1","author":"Mora","year":"2008","journal-title":"Mucosal Immunol"},{"issue":"67","key":"10.1016\/j.gendis.2026.102200_bib96","doi-asserted-by":"crossref","first-page":"eabf5314","DOI":"10.1126\/sciimmunol.abf5314","article-title":"Lung-resident memory B cells established after pulmonary influenza infection display distinct transcriptional and phenotypic profiles","volume":"7","author":"Tan","year":"2022","journal-title":"Sci Immunol"},{"issue":"4","key":"10.1016\/j.gendis.2026.102200_bib97","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.immuni.2022.03.003","article-title":"Secondary influenza challenge triggers resident memory B cell migration and rapid relocation to boost antibody secretion at infected sites","volume":"55","author":"MacLean","year":"2022","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.gendis.2026.102200_bib98","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1073\/pnas.1115369109","article-title":"Memory B cells in the lung participate in protective humoral immune responses to pulmonary influenza virus reinfection","volume":"109","author":"Onodera","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.gendis.2026.102200_bib99","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1084\/jem.20030091","article-title":"Activation of virus-specific memory B cells in the absence of T cell help","volume":"199","author":"Hebeis","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.gendis.2026.102200_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1039194","article-title":"Tissue resident memory T cells- A new benchmark for the induction of vaccine-induced mucosal immunity","volume":"13","author":"Hassert","year":"2022","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.gendis.2026.102200_bib101","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1084\/jem.20181308","article-title":"CXCR6 regulates localization of tissue-resident memory CD8 T cells to the airways","volume":"216","author":"Wein","year":"2019","journal-title":"J Exp Med"},{"issue":"18","key":"10.1016\/j.gendis.2026.102200_bib102","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1128\/JVI.01069-10","article-title":"Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms","volume":"84","author":"Teijaro","year":"2010","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.gendis.2026.102200_bib103","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41385-021-00407-5","article-title":"IL-17 mediates protective immunity against nasal infection with Bordetella pertussis by mobilizing neutrophils, especially Siglec-F+ neutrophils","volume":"14","author":"Borkner","year":"2021","journal-title":"Mucosal Immunol"},{"issue":"11","key":"10.1016\/j.gendis.2026.102200_bib104","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41577-024-01040-6","article-title":"A guide to adaptive immune memory","volume":"24","author":"Lam","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.gendis.2026.102200_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1745319","article-title":"Intranasal vaccines adjuvanted with Nexavant demonstrate robust protective efficacy by inducing both mucosal and systemic immunity in a murine model","volume":"16","author":"Ko","year":"2026","journal-title":"Front Immunol"},{"key":"10.1016\/j.gendis.2026.102200_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1218565","article-title":"The lung-gut crosstalk in respiratory and inflammatory bowel disease","volume":"13","author":"Du","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.gendis.2026.102200_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.608645","article-title":"Importance of type I and III interferons at respiratory and intestinal barrier surfaces","volume":"11","author":"Stanifer","year":"2020","journal-title":"Front Immunol"},{"issue":"49","key":"10.1016\/j.gendis.2026.102200_bib108","doi-asserted-by":"crossref","first-page":"eabd1554","DOI":"10.1126\/sciimmunol.abd1554","article-title":"Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19","volume":"5","author":"Lee","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.gendis.2026.102200_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1201658","article-title":"Mechanisms of airway epithelial injury and abnormal repair in asthma and COPD","volume":"14","author":"Raby","year":"2023","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.gendis.2026.102200_bib110","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.190109","article-title":"The protective and pathogenic roles of IL-17 in viral infections: friend or foe?","volume":"9","author":"Ma","year":"2019","journal-title":"Open Biol"},{"key":"10.1016\/j.gendis.2026.102200_bib111","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cytogfr.2025.01.002","article-title":"Interleukin-17: a pleiotropic cytokine implicated in inflammatory, infectious, and malignant disorders","volume":"83","author":"Saran","year":"2025","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"10.1016\/j.gendis.2026.102200_bib112","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41579-018-0001-8","article-title":"Streptococcus pneumoniae: transmission, colonization and invasion","volume":"16","author":"Weiser","year":"2018","journal-title":"Nat Rev Microbiol"},{"issue":"9","key":"10.1016\/j.gendis.2026.102200_bib113","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s12275-024-00167-4","article-title":"Microbiome-mucosal immunity nexus: driving forces in respiratory disease progression","volume":"62","author":"Park","year":"2024","journal-title":"J Microbiol"},{"issue":"2","key":"10.1016\/j.gendis.2026.102200_bib114","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/mi.2016.108","article-title":"The respiratory tract microbiome and lung inflammation: a two-way street","volume":"10","author":"Huffnagle","year":"2017","journal-title":"Mucosal Immunol"},{"issue":"6","key":"10.1016\/j.gendis.2026.102200_bib115","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.jaip.2023.04.015","article-title":"The Th17\/IL-17 axis and host defense against fungal infections","volume":"11","author":"Tangye","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.gendis.2026.102200_bib116","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s40257-022-00686-z","article-title":"Candida Infection associated with anti-IL-17 medication: a systematic analysis and review of the literature","volume":"23","author":"Yamanaka-Takaichi","year":"2022","journal-title":"Am J Clin Dermatol"},{"issue":"8","key":"10.1016\/j.gendis.2026.102200_bib117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010740","article-title":"Type I interferons during host-fungus interactions: is antifungal immunity going viral?","volume":"18","author":"Pekmezovic","year":"2022","journal-title":"PLoS Pathog"},{"issue":"4","key":"10.1016\/j.gendis.2026.102200_bib118","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/myc.13433","article-title":"COVID-19-associated aspergillosis in a Brazilian referral centre: diagnosis, risk factors and outcomes","volume":"65","author":"de Almeida","year":"2022","journal-title":"Mycoses"},{"issue":"6","key":"10.1016\/j.gendis.2026.102200_bib119","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S2213-2600(20)30157-0","article-title":"Chronic respiratory diseases: a global view","volume":"8","author":"Labaki","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"17","key":"10.1016\/j.gendis.2026.102200_bib120","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.3390\/cells11172764","article-title":"Current understanding of asthma pathogenesis and biomarkers","volume":"11","author":"Habib","year":"2022","journal-title":"Cells"},{"issue":"Suppl 1","key":"10.1016\/j.gendis.2026.102200_bib121","first-page":"S2","article-title":"Asthma: definitions and pathophysiology","volume":"5","author":"Mims","year":"2015","journal-title":"Int Forum Allergy Rhinol"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib122","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.alit.2017.08.011","article-title":"Role of airway epithelial barrier dysfunction in pathogenesis of asthma","volume":"67","author":"Gon","year":"2018","journal-title":"Allergol Int"},{"key":"10.1016\/j.gendis.2026.102200_bib123","doi-asserted-by":"crossref","first-page":"102572","DOI":"10.1016\/j.ebiom.2019.11.033","article-title":"Airway epithelial cell differentiation relies on deficient Hedgehog signalling in COPD","volume":"51","author":"Belgacemi","year":"2020","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.gendis.2026.102200_bib124","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3390\/biom14030294","article-title":"TNF superfamily and ILC2 activation in asthma","volume":"14","author":"Matsuyama","year":"2024","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.gendis.2026.102200_bib125","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jaci.2021.09.013","article-title":"Airway administration of OM-85, a bacterial lysate, blocks experimental asthma by targeting dendritic cells and the epithelium\/IL-33\/ILC2 axis","volume":"149","author":"Pivniouk","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"21","key":"10.1016\/j.gendis.2026.102200_bib126","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.3390\/cells12212556","article-title":"Regulatory ILC2: role of IL-10 producing ILC2 in asthma","volume":"12","author":"Emami","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib127","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaci.2015.05.037","article-title":"Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia","volume":"137","author":"Smith","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib128","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.70147","article-title":"Tezepelumab improves small airways dysfunction in severe asthma: a 52-week real-world study","volume":"16","author":"Menzella","year":"2026","journal-title":"Clin Transl Allergy"},{"issue":"3","key":"10.1016\/j.gendis.2026.102200_bib129","doi-asserted-by":"crossref","first-page":"239","DOI":"10.18176\/jiaci.1150","article-title":"Severe asthma and chronic rhinosinusitis with nasal polyps: simultaneous response to dupilumab","volume":"36","author":"L\u00f3pez-Gonz\u00e1lez","year":"2026","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"11","key":"10.1016\/j.gendis.2026.102200_bib130","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1164\/rccm.201703-0561OC","article-title":"Bronchial epithelial IgA secretion is impaired in asthma. role of IL-4\/IL-13","volume":"197","author":"Ladjemi","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.gendis.2026.102200_bib131","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3390\/cells11081324","article-title":"Secretory immunoglobulin a immunity in chronic obstructive respiratory diseases","volume":"11","author":"de Fays","year":"2022","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.gendis.2026.102200_bib132","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10875-010-9438-x","article-title":"Selective IgA deficiency in children in Israel","volume":"30","author":"Shkalim","year":"2010","journal-title":"J Clin Immunol"},{"issue":"6","key":"10.1016\/j.gendis.2026.102200_bib133","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/ni.3443","article-title":"Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs","volume":"17","author":"Silver","year":"2016","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.gendis.2026.102200_bib134","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/ni.3444","article-title":"IL-1\u03b2, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs","volume":"17","author":"Bal","year":"2016","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.gendis.2026.102200_bib135","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2174\/1871530319666190116115226","article-title":"Interleukin-17A: a potential therapeutic target in chronic lung diseases","volume":"19","author":"Shaikh","year":"2019","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"14","key":"10.1016\/j.gendis.2026.102200_bib136","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.3390\/cells11142132","article-title":"IL-17 cytokines and chronic lung diseases","volume":"11","author":"Ritzmann","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.gendis.2026.102200_bib137","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fimmu.2019.00092","article-title":"Type 3 ILCs in lung disease","volume":"10","author":"Ardain","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib138","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1164\/ajrccm.163.1.9912137","article-title":"Reduced epithelial expression of secretory component in small airways correlates with airflow obstruction in chronic obstructive pulmonary disease","volume":"163","author":"Pilette","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib139","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s40001-023-01282-5","article-title":"SIgA in various pulmonary diseases","volume":"28","author":"Wang","year":"2023","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.gendis.2026.102200_bib140","doi-asserted-by":"crossref","first-page":"11240","DOI":"10.1038\/ncomms11240","article-title":"Airway bacteria drive a progressive COPD-like phenotype in mice with polymeric immunoglobulin receptor deficiency","volume":"7","author":"Richmond","year":"2016","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.gendis.2026.102200_bib141","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1164\/rccm.201311-1971OC","article-title":"Polymeric immunoglobulin receptor down-regulation in chronic obstructive pulmonary disease. Persistence in the cultured epithelium and role of transforming growth factor-\u03b2","volume":"190","author":"Gohy","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"21","key":"10.1016\/j.gendis.2026.102200_bib142","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1001\/jama.2023.8120","article-title":"Cystic fibrosis: a review","volume":"329","author":"Ong","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib143","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1038\/s41467-019-09883-7","article-title":"IL-1\u03b2, IL-23, and TGF-\u03b2 drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation","volume":"10","author":"Golebski","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.gendis.2026.102200_bib144","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3389\/fimmu.2020.00691","article-title":"ILC2 lung-homing in cystic fibrosis patients: functional involvement of CCR6 and impact on respiratory failure","volume":"11","author":"Schulz-Kuhnt","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.gendis.2026.102200_bib145","doi-asserted-by":"crossref","first-page":"102974","DOI":"10.1016\/j.ebiom.2020.102974","article-title":"Lung immunoglobulin A immunity dysregulation in cystic fibrosis","volume":"60","author":"Collin","year":"2020","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.gendis.2026.102200_bib146","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.anai.2018.07.003","article-title":"Salivary IgA deficiency in a patient with cystic fibrosis (genotype M470V\/V520F)","volume":"121","author":"Oh","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.gendis.2026.102200_bib147","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1164\/rccm.202401-0043LE","article-title":"The IgA-pIgR system is dysregulated in idiopathic pulmonary fibrosis","volume":"210","author":"Plant\u00e9-Bordeneuve","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.gendis.2026.102200_bib148","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1007\/s13346-025-01909-6","article-title":"Inhaled biologics for respiratory diseases: clinical potential and emerging technologies","volume":"15","author":"Shaibie","year":"2025","journal-title":"Drug Deliv Transl Res"},{"issue":"8","key":"10.1016\/j.gendis.2026.102200_bib149","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3390\/vaccines13080825","article-title":"Immunogenicity, safety, and protective efficacy of mucosal vaccines against respiratory infectious diseases: a systematic review and meta-analysis","volume":"13","author":"Chen","year":"2025","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"10.1016\/j.gendis.2026.102200_bib150","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41577-022-00813-1","article-title":"Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection","volume":"23","author":"Zhang","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.gendis.2026.102200_bib151","doi-asserted-by":"crossref","first-page":"100218","DOI":"10.1016\/j.xcrm.2021.100218","article-title":"Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters","volume":"2","author":"Piepenbrink","year":"2021","journal-title":"Cell Rep Med"},{"issue":"5","key":"10.1016\/j.gendis.2026.102200_bib152","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/j.ymthe.2022.02.013","article-title":"Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy","volume":"30","author":"Minenkova","year":"2022","journal-title":"Mol Ther"},{"issue":"8","key":"10.1016\/j.gendis.2026.102200_bib153","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.cell.2022.03.009","article-title":"Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody","volume":"185","author":"Li","year":"2022","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.gendis.2026.102200_bib154","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1093\/cid\/ciac448","article-title":"Nasal spray of neutralizing monoclonal antibody 35B5 confers potential prophylaxis against severe acute respiratory syndrome coronavirus 2 variants of concern: a small-scale clinical trial","volume":"76","author":"Lin","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S2213-2600(20)30320-9","article-title":"Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b trial","volume":"9","author":"Cunningham","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.gendis.2026.102200_bib156","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2021.1940650","article-title":"Inhaled antibodies: quality and performance considerations","volume":"18","author":"Hickey","year":"2022","journal-title":"Hum Vaccin Immunother"},{"issue":"12","key":"10.1016\/j.gendis.2026.102200_bib157","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1016\/j.cell.2021.05.005","article-title":"Tackling COVID-19 with neutralizing monoclonal antibodies","volume":"184","author":"Corti","year":"2021","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.gendis.2026.102200_bib158","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41577-020-00410-0","article-title":"The role of IgG Fc receptors in antibody-dependent enhancement","volume":"20","author":"Bournazos","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"6530","key":"10.1016\/j.gendis.2026.102200_bib159","doi-asserted-by":"crossref","first-page":"eabe6230","DOI":"10.1126\/science.abe6230","article-title":"Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape","volume":"371","author":"Koenig","year":"2021","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib160","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.1038\/s41467-021-25480-z","article-title":"A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19","volume":"12","author":"Huo","year":"2021","journal-title":"Nat Commun"},{"issue":"27","key":"10.1016\/j.gendis.2026.102200_bib161","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.gendis.2026.102200_bib162","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"7838","key":"10.1016\/j.gendis.2026.102200_bib163","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/d41586-020-03542-4","article-title":"US authorization of first COVID vaccine marks new phase in safety monitoring","volume":"588","author":"Ledford","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.gendis.2026.102200_bib164","doi-asserted-by":"crossref","first-page":"109400","DOI":"10.1016\/j.celrep.2021.109400","article-title":"A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters","volume":"36","author":"Bricker","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.gendis.2026.102200_bib165","article-title":"Intranasal HD-Ad-FS vaccine induces systemic and airway mucosal immunities against SARS-CoV-2 and systemic immunity against SARS-CoV-2 variants in mice and hamsters","volume":"15","author":"Zhou","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.gendis.2026.102200_bib166","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.781280","article-title":"An intranasal OMV-based vaccine induces high mucosal and systemic protecting immunity against a SARS-CoV-2 infection","volume":"12","author":"van der Ley","year":"2021","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.gendis.2026.102200_bib167","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0289373","article-title":"Route of administration significantly affects particle deposition and cellular recruitment","volume":"18","author":"Yisrael","year":"2023","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.gendis.2026.102200_bib168","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.155655","article-title":"Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans","volume":"7","author":"Jeyanathan","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.gendis.2026.102200_bib169","doi-asserted-by":"crossref","first-page":"102370","DOI":"10.1016\/j.coi.2023.102370","article-title":"Viral-vectored respiratory mucosal vaccine strategies","volume":"84","author":"Jeyanathan","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.gendis.2026.102200_bib170","doi-asserted-by":"crossref","first-page":"101347","DOI":"10.1016\/j.coviro.2023.101347","article-title":"Improvement of mucosal immunity by a live-attenuated SARS-CoV-2 nasal vaccine","volume":"62","author":"Yeung","year":"2023","journal-title":"Curr Opin Virol"},{"issue":"5","key":"10.1016\/j.gendis.2026.102200_bib171","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.vaccine.2022.12.058","article-title":"Revisiting live attenuated influenza vaccine efficacy among children in developing countries","volume":"41","author":"Bagga","year":"2023","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.gendis.2026.102200_bib172","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102775118","article-title":"Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy","volume":"118","author":"Wang","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.gendis.2026.102200_bib173","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","article-title":"Viral targets for vaccines against COVID-19","volume":"21","author":"Dai","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"39","key":"10.1016\/j.gendis.2026.102200_bib174","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.3748\/wjg.v11.i39.6159","article-title":"Receptor-binding domain of SARS-Cov spike protein: soluble expression in E. coli, purification and functional characterization","volume":"11","author":"Chen","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"47","key":"10.1016\/j.gendis.2026.102200_bib175","doi-asserted-by":"crossref","first-page":"7533","DOI":"10.1016\/j.vaccine.2020.09.061","article-title":"Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement","volume":"38","author":"Chen","year":"2020","journal-title":"Vaccine"},{"issue":"7830","key":"10.1016\/j.gendis.2026.102200_bib176","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-020-2599-8","article-title":"A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity","volume":"586","author":"Yang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.gendis.2026.102200_bib177","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jconrel.2024.01.017","article-title":"Protein subunit vaccines: promising frontiers against COVID-19","volume":"366","author":"Chavda","year":"2024","journal-title":"J Control Release"},{"issue":"12","key":"10.1016\/j.gendis.2026.102200_bib178","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/s41551-025-01431-7","article-title":"Enantiomer-dependent and modification-free DNA matrix as an adjuvant for subunit vaccines against SARS-CoV-2 or pneumococcal infections","volume":"9","author":"Li","year":"2025","journal-title":"Nat Biomed Eng"},{"issue":"10","key":"10.1016\/j.gendis.2026.102200_bib179","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1111\/bph.70340","article-title":"Empty lipid nanoparticles (eLNPs) with adjuvant activity induce potent immune responses","volume":"183","author":"Qiu","year":"2026","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib180","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12951-023-01816-3","article-title":"Enhanced mucosal immune responses and reduced viral load in the respiratory tract of ferrets to intranasal lipid nanoparticle-based SARS-CoV-2 proteins and mRNA vaccines","volume":"21","author":"Boley","year":"2023","journal-title":"J Nanobiotechnology"},{"issue":"36","key":"10.1016\/j.gendis.2026.102200_bib181","doi-asserted-by":"crossref","first-page":"24650","DOI":"10.1021\/acsnano.3c10797","article-title":"Nanoplatform based intranasal vaccines: current progress and clinical challenges","volume":"18","author":"Bai","year":"2024","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib182","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/molecules27010204","article-title":"Development and optimization of Chitosan nanoparticle-based intranasal vaccine carrier","volume":"27","author":"Gao","year":"2021","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.gendis.2026.102200_bib183","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3390\/md18120605","article-title":"The application of mucoadhesive chitosan nanoparticles in nasal drug delivery","volume":"18","author":"Shim","year":"2020","journal-title":"Mar Drugs"},{"issue":"25","key":"10.1016\/j.gendis.2026.102200_bib184","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1016\/j.vaccine.2021.04.069","article-title":"A nanogel-based trivalent PspA nasal vaccine protects macaques from intratracheal challenge with pneumococci","volume":"39","author":"Nakahashi-Ouchida","year":"2021","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib185","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41541-023-00700-3","article-title":"Cationic-nanogel nasal vaccine containing the ectodomain of RSV-small hydrophobic protein induces protective immunity in rodents","volume":"8","author":"Umemoto","year":"2023","journal-title":"NPJ Vaccines"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib186","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41392-020-00434-x","article-title":"Cationic nanocarriers as potent adjuvants for recombinant S-RBD vaccine of SARS-CoV-2","volume":"5","author":"Lei","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib187","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-76163-w","article-title":"A self-adjuvanted VLPs-based Covid-19 vaccine proven versatile, safe, and highly protective","volume":"14","author":"Vuitika","year":"2024","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.gendis.2026.102200_bib188","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/v16060843","article-title":"Intranasal vaccination with a respiratory-syncytial-virus-based virus-like particle displaying the G protein conserved region induces severe weight loss and pathology upon challenge with wildtype respiratory syncytial virus","volume":"16","author":"Terh\u00fcja","year":"2024","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib189","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41392-023-01408-5","article-title":"Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.gendis.2026.102200_bib190","doi-asserted-by":"crossref","first-page":"16030","DOI":"10.1038\/mtm.2016.30","article-title":"Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens","volume":"3","author":"Afkhami","year":"2016","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.gendis.2026.102200_bib191","doi-asserted-by":"crossref","first-page":"101334","DOI":"10.1016\/j.coviro.2023.101334","article-title":"Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19","volume":"61","author":"Afkhami","year":"2023","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.gendis.2026.102200_bib192","doi-asserted-by":"crossref","first-page":"102027","DOI":"10.1016\/j.omtn.2023.09.004","article-title":"Construction and application of adenoviral vectors","volume":"34","author":"Zhang","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"10.1016\/j.gendis.2026.102200_bib193","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.coi.2011.03.006","article-title":"Viral vectors as vaccine platforms: deployment in sight","volume":"23","author":"Rollier","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.gendis.2026.102200_bib194","doi-asserted-by":"crossref","first-page":"124480","DOI":"10.1016\/j.ijpharm.2024.124480","article-title":"Development of a novel adenovirus serotype 35 vector vaccine possessing an RGD peptide in the fiber knob and the E4 orf 4, 6, and 6\/7 regions of adenovirus serotype 5","volume":"662","author":"Onishi","year":"2024","journal-title":"Int J Pharm"},{"issue":"9","key":"10.1016\/j.gendis.2026.102200_bib195","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1128\/JVI.02407-10","article-title":"Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman Primates against ebolavirus challenge","volume":"85","author":"Geisbert","year":"2011","journal-title":"J Virol"},{"issue":"10269","key":"10.1016\/j.gendis.2026.102200_bib196","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib197","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1186\/s12864-021-08061-8","article-title":"Distinct patterns of whole blood transcriptional responses are induced in mice following immunisation with adenoviral and poxviral vector vaccines encoding the same antigen","volume":"22","author":"Sheerin","year":"2021","journal-title":"BMC Genomics"},{"issue":"3","key":"10.1016\/j.gendis.2026.102200_bib198","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/cei\/uxad003","article-title":"Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults","volume":"211","author":"Green","year":"2023","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"10.1016\/j.gendis.2026.102200_bib199","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S2213-2600(23)00049-8","article-title":"Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial","volume":"11","author":"Tang","year":"2023","journal-title":"Lancet Respir Med"},{"issue":"10","key":"10.1016\/j.gendis.2026.102200_bib200","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S1473-3099(23)00350-X","article-title":"Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial","volume":"23","author":"Li","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.gendis.2026.102200_bib201","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S1473-3099(21)00396-0","article-title":"Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial","volume":"21","author":"Wu","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.gendis.2026.102200_bib202","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1186478","article-title":"Combined intranasal and intramuscular parainfluenza 5-, Simian adenovirus ChAdOx1- and poxvirus MVA-vectored vaccines induce synergistically HIV-1-specific T cells in the mucosa","volume":"14","author":"Beavis","year":"2023","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.gendis.2026.102200_bib203","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1007\/s12602-025-10667-3","article-title":"Genetically modified lactic acid bacteria: a promising mucosal delivery vector for vaccines","volume":"18","author":"Chowdhury","year":"2026","journal-title":"Probiotics Antimicrob Proteins"},{"key":"10.1016\/j.gendis.2026.102200_bib204","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ijbiomac.2021.08.232","article-title":"Mucosal IgA response elicited by intranasal immunization of Lactobacillus plantarum expressing surface-displayed RBD protein of SARS-CoV-2","volume":"190","author":"Li","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.gendis.2026.102200_bib205","doi-asserted-by":"crossref","first-page":"102388","DOI":"10.1016\/j.coi.2023.102388","article-title":"Challenges and opportunities in the development of mucosal mRNA vaccines","volume":"85","author":"Kirtane","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.gendis.2026.102200_bib206","doi-asserted-by":"crossref","first-page":"103788","DOI":"10.1016\/j.ebiom.2021.103788","article-title":"Mucosal immune response in BNT162b2 COVID-19 vaccine recipients","volume":"75","author":"Azzi","year":"2022","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.gendis.2026.102200_bib207","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3390\/vaccines12060670","article-title":"mRNA technology and mucosal immunization","volume":"12","author":"Toniolo","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"10.1016\/j.gendis.2026.102200_bib208","doi-asserted-by":"crossref","first-page":"102654","DOI":"10.1016\/j.omtn.2025.102654","article-title":"Intranasal mRNA vaccines: targeting mucosal immunity through optimized delivery","volume":"36","author":"Pandey","year":"2025","journal-title":"Mol Ther Nucleic Acids"},{"issue":"8","key":"10.1016\/j.gendis.2026.102200_bib209","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3390\/biom14081036","article-title":"Enhancing vaccine efficacy and stability: a review of the utilization of nanoparticles in mRNA vaccines","volume":"14","author":"Parvin","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.gendis.2026.102200_bib210","article-title":"Development and delivery systems of mRNA vaccines","volume":"9","author":"Liu","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"issue":"11","key":"10.1016\/j.gendis.2026.102200_bib211","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles-from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"issue":"709","key":"10.1016\/j.gendis.2026.102200_bib212","doi-asserted-by":"crossref","first-page":"eabq0603","DOI":"10.1126\/scitranslmed.abq0603","article-title":"Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination","volume":"15","author":"Suberi","year":"2023","journal-title":"Sci Transl Med"},{"issue":"38","key":"10.1016\/j.gendis.2026.102200_bib213","doi-asserted-by":"crossref","first-page":"eadh1655","DOI":"10.1126\/sciadv.adh1655","article-title":"Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection","volume":"9","author":"Baldeon","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.gendis.2026.102200_bib214","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jconrel.2023.09.031","article-title":"Spray dried lipid nanoparticle formulations enable intratracheal delivery of mRNA","volume":"363","author":"Friis","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.gendis.2026.102200_bib215","doi-asserted-by":"crossref","first-page":"114266","DOI":"10.1016\/j.ejpb.2024.114266","article-title":"Lipid nanoparticles for local delivery of mRNA to the respiratory tract: effect of PEG-lipid content and administration route","volume":"198","author":"Ongun","year":"2024","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"10.1016\/j.gendis.2026.102200_bib216","doi-asserted-by":"crossref","first-page":"102547","DOI":"10.1016\/j.omtn.2025.102547","article-title":"Deconvolution of cargo delivery and immunogenicity following intranasal delivery of mRNA lipid nanoparticle vaccines","volume":"36","author":"Vu","year":"2025","journal-title":"Mol Ther Nucleic Acids"},{"issue":"9","key":"10.1016\/j.gendis.2026.102200_bib217","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41565-023-01404-4","article-title":"Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines","volume":"18","author":"Han","year":"2023","journal-title":"Nat Nanotechnol"},{"issue":"7","key":"10.1016\/j.gendis.2026.102200_bib218","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1021\/acs.nanolett.2c04883","article-title":"STING agonist-derived LNP-mRNA vaccine enhances protective immunity against SARS-CoV-2","volume":"23","author":"Zhang","year":"2023","journal-title":"Nano Lett"},{"issue":"26","key":"10.1016\/j.gendis.2026.102200_bib219","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202312026","article-title":"Physicochemical targeting of lipid nanoparticles to the lungs induces clotting: mechanisms and solutions","volume":"36","author":"Omo-Lamai","year":"2024","journal-title":"Adv Mater"},{"issue":"12","key":"10.1016\/j.gendis.2026.102200_bib220","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/s41587-024-02486-8","article-title":"Challenges for developing broad-based mucosal vaccines for respiratory viruses","volume":"42","author":"Seo","year":"2024","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib221","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41541-023-00654-6","article-title":"Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities-workshop report","volume":"8","author":"Knisely","year":"2023","journal-title":"NPJ Vaccines"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib222","doi-asserted-by":"crossref","first-page":"8959","DOI":"10.1038\/s41467-024-52863-9","article-title":"MINCLE and TLR9 agonists synergize to induce Th1\/Th17 vaccine memory and mucosal recall in mice and non-human Primates","volume":"15","author":"Woodworth","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib223","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41541-025-01103-2","article-title":"A systems biology approach to define SARS-CoV-2 correlates of protection","volume":"10","author":"Brady","year":"2025","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.gendis.2026.102200_bib224","doi-asserted-by":"crossref","first-page":"104585","DOI":"10.1016\/j.ebiom.2023.104585","article-title":"Mucosal vaccines for SARS-CoV-2: triumph of hope over experience","volume":"92","author":"Pilapitiya","year":"2023","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.gendis.2026.102200_bib225","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41590-024-01743-x","article-title":"Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection","volume":"25","author":"Ying","year":"2024","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.gendis.2026.102200_bib226","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13346-021-00940-7","article-title":"Intranasal drug delivery for treatment of Alzheimer\u2019s disease","volume":"11","author":"Fonseca","year":"2021","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.gendis.2026.102200_bib227","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biomaterials.2018.10.041","article-title":"M cell targeting engineered biomaterials for effective vaccination","volume":"192","author":"Islam","year":"2019","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.gendis.2026.102200_bib228","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.vaccine.2021.12.057","article-title":"Intranasal immunization with a Middle East respiratory syndrome-coronavirus antigen conjugated to the M-cell targeting ligand Co4B enhances antigen-specific mucosal and systemic immunity and protects against infection","volume":"40","author":"Yang","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib229","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1038\/s41598-023-31198-3","article-title":"Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist riboxxim\u2122 elicits strong antibody and T-cell responses in mice","volume":"13","author":"Horvath","year":"2023","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.gendis.2026.102200_bib230","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1021\/acs.bioconjchem.7b00738","article-title":"Targeted strategies for mucosal vaccination","volume":"29","author":"Longet","year":"2018","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.gendis.2026.102200_bib231","doi-asserted-by":"crossref","first-page":"101762","DOI":"10.1016\/j.smim.2023.101762","article-title":"Targeting dendritic cells to advance cross-presentation and vaccination outcomes","volume":"68","author":"Macri","year":"2023","journal-title":"Semin Immunol"},{"issue":"3","key":"10.1016\/j.gendis.2026.102200_bib232","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13128","article-title":"Intranasal delivery of a cDC1 targeted influenza vaccine with poly(I: C) enhances T cell responses and protects against influenza infection","volume":"95","author":"Lys\u00e9n","year":"2022","journal-title":"Scand J Immunol"},{"issue":"7","key":"10.1016\/j.gendis.2026.102200_bib233","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nri2103","article-title":"Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo","volume":"7","author":"Villadangos","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.gendis.2026.102200_bib234","doi-asserted-by":"crossref","first-page":"104947","DOI":"10.1016\/j.ebiom.2023.104947","article-title":"Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine","volume":"99","author":"Odak","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.gendis.2026.102200_bib235","doi-asserted-by":"crossref","first-page":"126909","DOI":"10.1016\/j.vaccine.2025.126909","article-title":"Development of broadly protective coronavirus vaccines: a joint NIAID-CEPI workshop report","volume":"54","author":"Gordon","year":"2025","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.gendis.2026.102200_bib236","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41423-023-01116-8","article-title":"In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms","volume":"21","author":"Cankat","year":"2024","journal-title":"Cell Mol Immunol"},{"issue":"9","key":"10.1016\/j.gendis.2026.102200_bib237","first-page":"636","article-title":"Towards a universal flu vaccine","volume":"21","author":"Crunkhorn","year":"2022","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.gendis.2026.102200_bib238","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3390\/ijms26031263","article-title":"SARS-CoV-2 variants: genetic insights, epidemiological tracking, and implications for vaccine strategies","volume":"26","author":"Alhamlan","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.gendis.2026.102200_bib239","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1016\/S2666-5247(22)00390-1","article-title":"Efficacy of SARS-CoV-2 vaccines and the dose\u2013response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials","volume":"4","author":"Yang","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.gendis.2026.102200_bib240","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1343716","article-title":"High frequencies of alpha common cold coronavirus\/SARS-CoV-2 cross-reactive functional CD4+ and CD8+ memory T cells are associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patients","volume":"15","author":"Coulon","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.gendis.2026.102200_bib241","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1328905","article-title":"Cross-protection induced by highly conserved human B, CD4+, and CD8+ T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern","volume":"15","author":"Prakash","year":"2024","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.gendis.2026.102200_bib242","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2024.12.015","article-title":"Designed mosaic nanoparticles enhance cross-reactive immune responses in mice","volume":"188","author":"Wang","year":"2025","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.gendis.2026.102200_bib243","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41551-023-01094-2","article-title":"A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecoviruses","volume":"9","author":"Vishwanath","year":"2025","journal-title":"Nat Biomed Eng"},{"issue":"5","key":"10.1016\/j.gendis.2026.102200_bib244","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.3390\/ijms24054371","article-title":"Can T cells abort SARS-CoV-2 and other viral infections?","volume":"24","author":"Swadling","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib245","article-title":"A novel orf virus vector-based COVID-19 booster vaccine shows cross-neutralizing activity in the absence of anti-vector neutralizing immunity","volume":"20","author":"Klinkardt","year":"2024","journal-title":"Hum Vaccin Immunother"},{"issue":"30","key":"10.1016\/j.gendis.2026.102200_bib246","doi-asserted-by":"crossref","first-page":"eade3470","DOI":"10.1126\/sciadv.ade3470","article-title":"Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivor","volume":"9","author":"Chia","year":"2023","journal-title":"Sci Adv"},{"issue":"5","key":"10.1016\/j.gendis.2026.102200_bib247","doi-asserted-by":"crossref","first-page":"100634","DOI":"10.1016\/j.xcrm.2022.100634","article-title":"Variant-specific vaccination induces systems immune responses and potent in vivo protection against SARS-CoV-2","volume":"3","author":"Peng","year":"2022","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib248","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/vaccines13010030","article-title":"Antigen delivery platforms for next-generation coronavirus vaccines","volume":"13","author":"Chentoufi","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.gendis.2026.102200_bib249","article-title":"Towards broad-spectrum protection: the development and challenges of combined respiratory virus vaccines","volume":"14","author":"Wang","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"issue":"22","key":"10.1016\/j.gendis.2026.102200_bib250","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1001\/jama.2025.5646","article-title":"Immunogenicity and safety of influenza and COVID-19 multicomponent vaccine in adults \u226550 years: a randomized clinical trial","volume":"333","author":"Rudman","year":"2025","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.gendis.2026.102200_bib251","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/infdis\/jiae507","article-title":"Combination seasonal vaccines for influenza, respiratory syncytial virus, severe acute respiratory syndrome coronavirus 2, and other pathogens","volume":"231","author":"Dobrzynski","year":"2025","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.gendis.2026.102200_bib252","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.molmed.2022.10.009","article-title":"Nasal vaccines: solutions for respiratory infectious diseases","volume":"29","author":"Nakahashi-Ouchida","year":"2023","journal-title":"Trends Mol Med"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib253","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/14760584.2023.2268724","article-title":"Mucosal vaccination: onward and upward","volume":"22","author":"Tsai","year":"2023","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"10.1016\/j.gendis.2026.102200_bib254","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.3390\/pharmaceutics15061720","article-title":"The upper nasal space: option for systemic drug delivery, mucosal vaccines and \u201cnose-to-brain\u201d","volume":"15","author":"Shrewsbury","year":"2023","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.gendis.2026.102200_bib255","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1056\/NEJMp048006","article-title":"Nasal vaccination, Escherichia coliEnterotoxin, and Bell\u2019s palsy","volume":"350","author":"Couch","year":"2004","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.gendis.2026.102200_bib256","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell\u2019s palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.gendis.2026.102200_bib257","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2165\/11206860-000000000-00000","article-title":"Live attenuated influenza vaccine (FluMist\u00ae; fluenz\u2122): a review of its use in the prevention of seasonal influenza in children and adults","volume":"71","author":"Carter","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.gendis.2026.102200_bib258","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1284337","article-title":"Is it time to switch to a formulation other than the live attenuated poliovirus vaccine to prevent poliomyelitis?","volume":"11","author":"Devaux","year":"2024","journal-title":"Front Public Health"},{"issue":"8","key":"10.1016\/j.gendis.2026.102200_bib259","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70301","article-title":"Combining intramuscular and intranasal immunization with the MF59-adjuvanted respiratory syncytial virus pre-fusion protein subunit vaccine induces potent humoral and cellular immune responses in mice","volume":"6","author":"Shi","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.gendis.2026.102200_bib260","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2024.1428713","article-title":"Safety and efficacy of toll-like receptor agonists as therapeutic agents and vaccine adjuvants for infectious diseases in animals: a systematic review","volume":"11","author":"Oboge","year":"2024","journal-title":"Front Vet Sci"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib261","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s43556-025-00301-7","article-title":"Mucosal immunity and vaccination strategies: current insights and future perspectives","volume":"6","author":"Zhang","year":"2025","journal-title":"Mol Biomed"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib262","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.gendis.2026.102200_bib263","doi-asserted-by":"crossref","first-page":"115196","DOI":"10.1016\/j.addr.2024.115196","article-title":"Intranasal drug delivery: the interaction between nanoparticles and the nose-to-brain pathway","volume":"207","author":"Chen","year":"2024","journal-title":"Adv Drug Deliv Rev"},{"issue":"24","key":"10.1016\/j.gendis.2026.102200_bib264","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1016\/j.vaccine.2023.05.011","article-title":"Advances in intranasal vaccine delivery: a promising non-invasive route of immunization","volume":"41","author":"Kehagia","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.gendis.2026.102200_bib265","doi-asserted-by":"crossref","first-page":"125086","DOI":"10.1016\/j.ijpharm.2024.125086","article-title":"Computational study of the impact of nasal vestibule anatomy on nasal drug administration with nasal spray","volume":"669","author":"Shen","year":"2025","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib266","doi-asserted-by":"crossref","first-page":"18507","DOI":"10.1038\/s41598-025-03309-9","article-title":"Laminar fluid ejection device enables high yield and preservation of mRNA and SaRNA LNP formulations","volume":"15","author":"Ho","year":"2025","journal-title":"Sci Rep"},{"issue":"Suppl 2","key":"10.1016\/j.gendis.2026.102200_bib267","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1542\/peds.2025-074246LR","article-title":"Safety of LAIV vaccination in asthma or wheeze: a systematic review and GRADE assessment","volume":"156","author":"Kelso","year":"2025","journal-title":"Pediatrics"},{"key":"10.1016\/j.gendis.2026.102200_bib268","doi-asserted-by":"crossref","first-page":"127602","DOI":"10.1016\/j.vaccine.2025.127602","article-title":"Mucosal COVID-19 vaccines in clinical development","volume":"63","author":"Tscherne","year":"2025","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib269","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41541-025-01280-0","article-title":"Advances and prospects of respiratory mucosal vaccines: mechanisms, technologies, and clinical applications","volume":"10","author":"Li","year":"2025","journal-title":"NPJ Vaccines"},{"issue":"607","key":"10.1016\/j.gendis.2026.102200_bib270","doi-asserted-by":"crossref","first-page":"eabh0755","DOI":"10.1126\/scitranslmed.abh0755","article-title":"Intranasal ChAdOx1 nCoV-19\/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models","volume":"13","author":"van Doremalen","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.gendis.2026.102200_bib271","doi-asserted-by":"crossref","first-page":"104298","DOI":"10.1016\/j.ebiom.2022.104298","article-title":"Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: an open-label partially-randomised ascending dose phase I trial","volume":"85","author":"Madhavan","year":"2022","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.gendis.2026.102200_bib272","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S2213-2600(23)00349-1","article-title":"Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"11","author":"Zhu","year":"2023","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib273","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1038\/s41467-023-39560-9","article-title":"Intranasal influenza-vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response in hamsters","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib274","doi-asserted-by":"crossref","first-page":"iqaf007","DOI":"10.1093\/oxfimm\/iqaf007","article-title":"A user\u2019s guide to designing efficient and safe mucosal vaccines: challenges & potentials","volume":"6","author":"Sinha","year":"2025","journal-title":"Oxford Open Immunol"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib275","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/14760584.2024.2326094","article-title":"Progress and challenges in the clinical evaluation of immune responses to respiratory mucosal vaccines","volume":"23","author":"Zhang","year":"2024","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.gendis.2026.102200_bib276","article-title":"Exploring the standardized detection and sampling methods of human nasal SARS-CoV-2 RBD IgA","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.gendis.2026.102200_bib277","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41392-022-01002-1","article-title":"Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants","volume":"7","author":"Lei","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"10.1016\/j.gendis.2026.102200_bib278","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1016\/j.immuni.2025.08.009","article-title":"Multi-scaled transcriptomics of chronically inflamed nasal epithelium reveals immune-epithelial dynamics and tissue remodeling in nasal polyp formation","volume":"58","author":"Liao","year":"2025","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib279","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1038\/s41467-025-59353-6","article-title":"An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse models","volume":"16","author":"Anthi","year":"2025","journal-title":"Nat Commun"},{"issue":"7992","key":"10.1016\/j.gendis.2026.102200_bib280","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41586-023-06809-8","article-title":"Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization","volume":"624","author":"Ye","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.gendis.2026.102200_bib281","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2025.2475822","article-title":"Exploring the standardization of human nasal antibody measurements","volume":"14","author":"Zhang","year":"2025","journal-title":"Emerg Microb Infect"},{"issue":"10","key":"10.1016\/j.gendis.2026.102200_bib282","doi-asserted-by":"crossref","DOI":"10.1111\/irv.13358","article-title":"Meeting report: controlled human influenza virus infection model studies: current status and future directions for innovation","volume":"18","author":"Lane","year":"2024","journal-title":"Influenza Other Respir Viruses"}],"container-title":["Genes & Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304226001728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304226001728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:41:20Z","timestamp":1790012480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304226001728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":282,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2352304226001728"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2026.102200","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Respiratory mucosal immunity: Biological functions, diseases, prevention and therapy","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2026.102200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102200"}}